Home
Storia in 1 fonti
J.P. Morgan Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX)
J.P. Morgan analyst Anupam Rama maintained a Buy rating on First Tracks Biotherapeutics Inc yesterday and set a price target of $30.00. The comp...
Raccontata da
markets.businessinsider.com
- ·
J.P. Morgan Sticks to Its Buy Rating for AnaptysBio (ANAB)
In a report released yesterday, Anupam Rama from J.P. Morgan maintained a Buy rating on AnaptysBio, with a price target of $70.00. The company’s...
- ·
J.P. Morgan Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX)
J.P. Morgan analyst Anupam Rama maintained a Buy rating on First Tracks Biotherapeutics Inc yesterday and set a price target of $30.00. The comp...
- ·
J.P. Morgan Sticks to Its Buy Rating for Tenet Healthcare (THC)
J.P. Morgan analyst Benjamin Rossi maintained a Buy rating on Tenet Healthcare yesterday and set a price target of $260.00. The company’s shares...